Mikaela Sjöstrand

12.6k total citations · 3 hit papers
49 papers, 1.9k citations indexed

About

Mikaela Sjöstrand is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Mikaela Sjöstrand has authored 49 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Cardiology and Cardiovascular Medicine and 15 papers in Surgery. Recurrent topics in Mikaela Sjöstrand's work include Diabetes Treatment and Management (27 papers), Pancreatic function and diabetes (13 papers) and Cardiovascular Function and Risk Factors (12 papers). Mikaela Sjöstrand is often cited by papers focused on Diabetes Treatment and Management (27 papers), Pancreatic function and diabetes (13 papers) and Cardiovascular Function and Risk Factors (12 papers). Mikaela Sjöstrand collaborates with scholars based in Sweden, United States and United Kingdom. Mikaela Sjöstrand's co-authors include Peter Lönnroth, Marc S. Sabatine, Felipe A. Martínez, John J.V. McMurray, Lars Køber, Scott D. Solomon, Piotr Ponikowski, Anna Maria Langkilde, Olof Bengtsson and Silvio E. Inzucchi and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Mikaela Sjöstrand

49 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Trial to Evaluate the Effect of the Sodium–Glucose Co-Transporter 2 Inhibitor Dapagliflozin on Morbidity and Mortality in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction (DAPA-HF)

2019 259 citations John J.V. McMurray, David L. DeMets et al. European Journal of Heart Failure profile →
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF

2021 140 citations Kieran F. Docherty, Pardeep S. Jhund et al. profile →
Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection Fraction

2021 130 citations Pardeep S. Jhund, Kieran F. Docherty et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mikaela Sjöstrand Sweden	22	1.1k	824	452	451	295	49	1.9k
Eiichi Akiyama Japan	26	530 0.5×	1.3k 1.6×	313 0.7×	503 1.1×	231 0.8×	96	2.3k
Alexander Tenenbaum Israel	26	669 0.6×	852 1.0×	341 0.8×	458 1.0×	189 0.6×	58	1.9k
Pitt Lim United Kingdom	28	859 0.8×	1.5k 1.8×	218 0.5×	857 1.9×	205 0.7×	94	2.7k
Eisaku Harada Japan	25	745 0.7×	1.7k 2.1×	376 0.8×	581 1.3×	469 1.6×	53	2.6k
Yoh Miyashita Japan	29	812 0.7×	1.3k 1.6×	276 0.6×	883 2.0×	330 1.1×	62	2.4k
Sylvie A. Ahn Belgium	21	492 0.4×	1.1k 1.4×	250 0.6×	411 0.9×	229 0.8×	75	1.9k
Kamel Mohammedi France	29	1.1k 1.0×	459 0.6×	469 1.0×	717 1.6×	278 0.9×	126	2.4k
Masaaki Konishi Japan	26	337 0.3×	1.2k 1.5×	417 0.9×	486 1.1×	650 2.2×	120	2.5k
Atsuhito Saiki Japan	29	551 0.5×	1.1k 1.4×	285 0.6×	674 1.5×	408 1.4×	105	2.2k
Elena Henkel Germany	16	1.6k 1.4×	529 0.6×	673 1.5×	347 0.8×	285 1.0×	34	2.3k

Countries citing papers authored by Mikaela Sjöstrand

Since Specialization

Citations

This map shows the geographic impact of Mikaela Sjöstrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikaela Sjöstrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikaela Sjöstrand more than expected).

Fields of papers citing papers by Mikaela Sjöstrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikaela Sjöstrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikaela Sjöstrand. The network helps show where Mikaela Sjöstrand may publish in the future.

Co-authorship network of co-authors of Mikaela Sjöstrand

This figure shows the co-authorship network connecting the top 25 collaborators of Mikaela Sjöstrand. A scholar is included among the top collaborators of Mikaela Sjöstrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikaela Sjöstrand. Mikaela Sjöstrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kondo, Toru, Ulrik M. Mogensen, Atefeh Talebi, et al.. (2024). Dapagliflozin and Days of Full Health Lost in the DAPA-HF Trial. Journal of the American College of Cardiology. 83(20). 1973–1986. 2 indexed citations

Yeoh, Su Ern, Kieran F. Docherty, Ross T. Campbell, et al.. (2023). Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF. Circulation. 147(22). 1670–1683. 24 indexed citations

Butt, Jawad H., Pooja Dewan, Ersilia M. DeFilippis, et al.. (2022). Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score. JACC Heart Failure. 10(8). 543–555. 16 indexed citations

Docherty, Kieran F., Inder S. Anand, Chern‐En Chiang, et al.. (2022). Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF. JACC Asia. 2(2). 139–153. 7 indexed citations

Yeoh, Su Ern, Kieran F. Docherty, Pardeep S. Jhund, et al.. (2022). Relationship of Dapagliflozin With Serum Sodium. JACC Heart Failure. 10(5). 306–318. 20 indexed citations

Docherty, Kieran F., Joanne Simpson, Pardeep S. Jhund, et al.. (2022). Effect of Dapagliflozin, Compared With Placebo, According to Baseline Risk in DAPA-HF. JACC Heart Failure. 10(2). 104–118. 6 indexed citations

Butt, Jawad H., José Carlos Nicolau, Subodh Verma, et al.. (2021). Efficacy and safety of dapagliflozin according to aetiology in heart failure with reduced ejection fraction: insights from the DAPA‐HF trial. European Journal of Heart Failure. 23(4). 601–613. 32 indexed citations

McMurray, John J.V., David L. DeMets, Silvio E. Inzucchi, et al.. (2019). A Trial to Evaluate the Effect of the Sodium–Glucose Co-Transporter 2 Inhibitor Dapagliflozin on Morbidity and Mortality in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction (DAPA-HF). European Journal of Heart Failure. 21(5). 665–675. 259 indexed citations breakdown →

McMurray, John J.V., David L. DeMets, Silvio E. Inzucchi, et al.. (2019). The Dapagliflozin And Prevention of Adverse-Outcomes in Heart Failure (DAPA-HF) Trial: Baseline Characteristics. European Journal of Heart Failure. 21(11). 1402–1411. 129 indexed citations

10.

Gutierrez, Pablo Morentin, John G. Swales, Jan W. Eriksson, et al.. (2015). Continuous inhibition of 11β‐hydroxysteroid dehydrogenase type I in adipose tissue leads to tachyphylaxis in humans and rats but not in mice. British Journal of Pharmacology. 172(20). 4806–4816. 7 indexed citations

11.

Sjöstrand, Mikaela, et al.. (2014). Saxagliptin improves glycemic control by modulating postprandial glucagon and C-peptide levels in Chinese patients with type 2 diabetes. Diabetes Research and Clinical Practice. 105(2). 185–191. 17 indexed citations

12.

Sjöstrand, Mikaela, Kenneth E. Carlson, Hans J. Arnqvist, et al.. (2013). Assessment of beta‐cell function in young patients with type 2 diabetes: arginine‐stimulated insulin secretion may reflect beta‐cell reserve. Journal of Internal Medicine. 275(1). 39–48. 12 indexed citations

13.

Jansson, Per‐Anders, Giuseppe Murdolo, Britta Nyström, et al.. (2010). Tadalafil increases muscle capillary recruitment and forearm glucose uptake in women with type 2 diabetes. Diabetologia. 53(10). 2205–2208. 32 indexed citations

14.

Sjöstrand, Mikaela, Per‐Anders Jansson, Jenny Palming, et al.. (2010). Repeated Measurements of 11β-HSD-1 Activity in Subcutaneous Adipose Tissue from Lean, Abdominally Obese, and Type 2 Diabetes Subjects – No Change Following a Mixed Meal. Hormone and Metabolic Research. 42(11). 798–802. 13 indexed citations

15.

Guðbjörnsdóttir, Soffia, Mikaela Sjöstrand, Lena Strindberg, & Peter Lönnroth. (2005). Decreased Muscle Capillary Permeability Surface Area in Type 2 Diabetic Subjects. The Journal of Clinical Endocrinology & Metabolism. 90(2). 1078–1082. 52 indexed citations

16.

Guðbjörnsdóttir, Soffia, Mikaela Sjöstrand, Lena Strindberg, John Wahren, & Peter Lönnroth. (2003). Direct Measurements of the Permeability Surface Area for Insulin and Glucose in Human Skeletal Muscle. The Journal of Clinical Endocrinology & Metabolism. 88(10). 4559–4564. 67 indexed citations

17.

Navegantes, Luiz Carlos Carvalho, Mikaela Sjöstrand, Soffia Guðbjörnsdóttir, et al.. (2003). Regulation and Counterregulation of Lipolysisin Vivo: Different Roles of Sympathetic Activation and Insulin. The Journal of Clinical Endocrinology & Metabolism. 88(11). 5515–5520. 36 indexed citations

18.

Holmäng, Agneta, et al.. (2000). Muscle glucose uptake is effectively activated by ischemia in type 2 diabetic subjects.. Diabetes. 49(7). 1178–1185. 13 indexed citations

19.

Sjöstrand, Mikaela, Agneta Holmäng, & Peter Lönnroth. (1999). Measurement of interstitial insulin in human muscle. American Journal of Physiology-Endocrinology and Metabolism. 276(1). E151–E154. 84 indexed citations

20.

Sjöstrand, Mikaela, et al.. (1989). Lung cell reactions in guinea pigs after inhalation of asbestos (amosite). Toxicology. 57(1). 1–14. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact